Biotech · Private company
Buzzard Pharmaceuticals
Track this companyFree. Adds Buzzard Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- isunakinraPhase 2 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- IsunakinraPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- PD-(L)1 InhibitorPhase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)PHASE2 · RECRUITING · started Jan 30, 2025ClinicalTrials.gov NCT06634875 · fetched Nov 12, 2026
- Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid TumorsPHASE1_PHASE2 · COMPLETED · started Sep 1, 2020ClinicalTrials.gov NCT04121442 · fetched Nov 12, 2026